Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M68.1Revenue (TTM) $M0.4Net Margin (%)-5,510.9Altman Z-Score-27.2
Enterprise Value $M62.1EPS (TTM) $-0.2Operating Margin %-7,585.7Piotroski F-Score3
P/E(ttm)--Beneish M-Score12.7Pre-tax Margin (%)-5,510.9Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-5.0Quick Ratio1.6Cash flow > EarningsN
Price/Sales1285-y EBITDA Growth Rate %-15.2Current Ratio1.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-122.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M135ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CVM

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CVM is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CVM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KERSTEN GEERT RCEO 2014-10-13Buy14,999$0.77-33.77view
KERSTEN GEERT RCEO 2013-12-30Buy300,000$0.6-15view
KERSTEN GEERT RChief Executive 2013-10-09Buy8,400$0.79-35.44view
YOUNG PETER RDirector 2013-06-19Buy2,500$2.4-78.75view
KERSTEN GEERT RChief Executive 2013-06-14Buy14,512$2.4-78.75view
KERSTEN GEERT RCEO 2013-05-20Buy4,000$2.5-79.6view
KERSTEN GEERT RCEO 2013-05-02Buy11,870$2.7-81.11view
YOUNG PETER RDirector 2013-03-27Buy2,500$2.3-77.83view
PRICHEP PATRICIA BSenior Vice President 2013-03-27Buy2,500$2.2-76.82view
KERSTEN GEERT RCEO 2013-03-26Buy34,813$2.1-75.71view

Press Releases about CVM :

Quarterly/Annual Reports about CVM:

News about CVM:

Articles On GuruFocus.com
CELSCISci Corp Reports Operating Results (10-Q) Feb 09 2011 
CELSCISci Corp Reports Operating Results (10-Q) Aug 16 2010 
CELSCISci Corp Reports Operating Results (10-Q) May 17 2010 
CELSCISci Corp Reports Operating Results (10-Q) Feb 12 2010 
CELSCISci Corp Reports Operating Results (10-Q/A) Feb 01 2010 
CELSCISci Corp Reports Operating Results (10-Q/A) Feb 01 2010 
CELSCISci Corp Reports Operating Results (10-Q/A) Jan 29 2010 
CELSCISci Corp Reports Operating Results (10-K) Jan 13 2010 
CELSCISci Corp Reports Operating Results (10-Q) Aug 14 2009 
CELSCISci Corp Reports Operating Results (10-Q) May 15 2009 

More From Other Websites
NEW STORY CEL-SCI Announces the Closing of Its $5 Million Registered Direct Offering May 24 2016
CEL-SCI Announces the Closing of Its $5 Million Registered Direct Offering May 24 2016
CEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... May 19 2016
CEL SCI CORP Financials May 19 2016
CEL-SCI Corp. :CVM-US: Earnings Analysis: Q2, 2016 By the Numbers May 18 2016
NEW STORY CEL-SCI Announces $5 Million Registered Direct Offering May 18 2016
CEL-SCI Announces $5 Million Registered Direct Offering May 18 2016
Cel-Sci reports 2Q loss May 10 2016
Cel-Sci reports 2Q loss May 10 2016
NEW STORY CEL-SCI Corporation Reports Second Quarter Fiscal Year 2016 Financial Results May 10 2016
CEL-SCI Corporation Reports Second Quarter Fiscal Year 2016 Financial Results May 10 2016
CEL SCI CORP Files SEC form 10-Q, Quarterly Report May 10 2016
NEW STORY CEL-SCI Reports Record Monthly Patient Enrollment in April for Its Phase 3 Head and Neck... May 02 2016
CEL-SCI Reports Record Monthly Patient Enrollment in April for Its Phase 3 Head and Neck Cancer... May 02 2016
CEL-SCI's Manufacturing of Cancer Killer Multikine Marks a World-Class Facility Apr 14 2016
CEL-SCI Corporation (NYSE MKT: CVM) is Selected as Bob Flaherty's Personal Pick in Flaherty's 35th... Apr 13 2016
NEW STORY CEL-SCI Featured on The RedChip Money Report Airing on Newsmax TV Apr 08 2016
CEL-SCI Featured on The RedChip Money Report Airing on Newsmax TV Apr 08 2016
NEW STORY CEL-SCI Reports Monthly Patient Enrollment in March for Its Phase 3 Head and Neck Cancer... Apr 01 2016
CEL-SCI Reports Monthly Patient Enrollment in March for Its Phase 3 Head and Neck Cancer Trial Apr 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)